Global Polymerase Chain Reaction Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Global Polymerase Chain Reaction Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview:
Polymerase chain reaction is a novel molecular diagnostic technology wherein DNA and RNA samples are amplified to form numerous copies of the same. This helps in better detection of diseases. This technology was developed by Kary Mullis in 1983. As more than two decades have passed since the evolution of PCR, the market is in a mature stage for standard PCR systems. In recent times, advances in technology have paved the way for the evolution of real-time PCR and digital PCR systems. Continuous technology advancements are making it more efficient and user-friendly, but the high cost of the instruments, servicing contracts, and reagents pose major challenges for the market, especially to the price-sensitive academics. Currently, the market players are involved in enhancing the capabilities of the PCR systems, and increasing its specificity and sensitivity.
Market Analysis:
The global polymerase chain reaction market is estimated to witness a CAGR of 9.91% during the forecast period 2017–2023. The global polymerase chain reaction market is analyzed based on four segments – products, application, end-users, and regions.
The market is witnessing an emerging trend of digital and droplet digital PCR technology, which is sensitive and accurate than the traditional method.
Regional Analysis:
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the leading region for the polymerase chain reaction market followed by Europe. Asia Pacific and ROW are set to be the emerging regions.
The markets in India, Brazil, and China are also expected to grow at a rapid pace during the forecast period.
Product Analysis:
The market is segmented into instruments, reagents & consumables, and software & services. Reagents hold the largest share of the global polymerase chain reaction market, and is expected to exhibit the fastest growth during the forecast period.
The increasing use of PCR in genetic and molecular analysis, the advent of digital PCR technology are the key factors driving the market. The high cost of the instrument, dearth of skilled labors, competing technologies, such as NGS and microarray and stringent government regulations are factors restricting the market growth.
Application Analysis:
The application of PCR is predominant in clinical diagnostics, life sciences, and others. The life sciences segment holds the largest share in the market. But the market for clinical diagnostics is expected to grow rapidly due to the increasing adoption of PCR systems for the diagnosis of diseases. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global polymerase chain reaction market.
End-users Analysis:
The end-users of PCR are hospitals, pharmaceutical & biotechnological companies, academics, and others (blood banks). Academics held a large market share in the PCR market in 2016. The demand for precise diagnosis of chronic diseases has increased in hospitals and diagnostic laboratories, which, in turn, will increase the growth rate of the global PCR market.
Key Players:
Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company, Promega, Qiagen N.V., and Agilent Technologies are the key players in the market.
Competitive Analysis:
At present, the reagents and consumables are dominating the global polymerase chain reaction market. A lot of new players are focusing on developing real-time PCR instruments and reagents to gain future business opportunities. Major players in the market are involved in acquiring small players with advanced technology products to maintain leadership. For instance, Merck KGaA acquired Sigma-Aldrich Corporation, a multinational biotechnology company, making them one of the major players in the PCR reagents market. In January 2017, Bio-Rad entered into an agreement to acquire RainDance Technologies to strengthen the digital PCR and liquid biopsy segments of the company.
Benefits:
The report provides complete details about the usage and adoption rate of PCR in various verticals and regions. This enables the key stakeholders to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward PCR adoption in the market. Moreover, the report provides details about the major challenges that are impacting the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business, increase their revenue, and analyze before investing or expanding the business in this market.
Key Stakeholders:
Title: Polymerase Chain Reaction (PCR) Market Trends 2017-2023
Desc: Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company will lead the Polymerase Chain Reaction (PCR) Market. Click to know more on Polymerase Chain Reaction (PCR) Market trends.
Keyword: Polymerase Chain Reaction, DNA, RNA, Polymerase Chain Reaction Market, Polymerase Chain Reaction Market Trends
Overview:
Polymerase chain reaction is a novel molecular diagnostic technology wherein DNA and RNA samples are amplified to form numerous copies of the same. This helps in better detection of diseases. This technology was developed by Kary Mullis in 1983. As more than two decades have passed since the evolution of PCR, the market is in a mature stage for standard PCR systems. In recent times, advances in technology have paved the way for the evolution of real-time PCR and digital PCR systems. Continuous technology advancements are making it more efficient and user-friendly, but the high cost of the instruments, servicing contracts, and reagents pose major challenges for the market, especially to the price-sensitive academics. Currently, the market players are involved in enhancing the capabilities of the PCR systems, and increasing its specificity and sensitivity.
Market Analysis:
The global polymerase chain reaction market is estimated to witness a CAGR of 9.91% during the forecast period 2017–2023. The global polymerase chain reaction market is analyzed based on four segments – products, application, end-users, and regions.
The market is witnessing an emerging trend of digital and droplet digital PCR technology, which is sensitive and accurate than the traditional method.
Regional Analysis:
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the leading region for the polymerase chain reaction market followed by Europe. Asia Pacific and ROW are set to be the emerging regions.
The markets in India, Brazil, and China are also expected to grow at a rapid pace during the forecast period.
Product Analysis:
The market is segmented into instruments, reagents & consumables, and software & services. Reagents hold the largest share of the global polymerase chain reaction market, and is expected to exhibit the fastest growth during the forecast period.
The increasing use of PCR in genetic and molecular analysis, the advent of digital PCR technology are the key factors driving the market. The high cost of the instrument, dearth of skilled labors, competing technologies, such as NGS and microarray and stringent government regulations are factors restricting the market growth.
Application Analysis:
The application of PCR is predominant in clinical diagnostics, life sciences, and others. The life sciences segment holds the largest share in the market. But the market for clinical diagnostics is expected to grow rapidly due to the increasing adoption of PCR systems for the diagnosis of diseases. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global polymerase chain reaction market.
End-users Analysis:
The end-users of PCR are hospitals, pharmaceutical & biotechnological companies, academics, and others (blood banks). Academics held a large market share in the PCR market in 2016. The demand for precise diagnosis of chronic diseases has increased in hospitals and diagnostic laboratories, which, in turn, will increase the growth rate of the global PCR market.
Key Players:
Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company, Promega, Qiagen N.V., and Agilent Technologies are the key players in the market.
Competitive Analysis:
At present, the reagents and consumables are dominating the global polymerase chain reaction market. A lot of new players are focusing on developing real-time PCR instruments and reagents to gain future business opportunities. Major players in the market are involved in acquiring small players with advanced technology products to maintain leadership. For instance, Merck KGaA acquired Sigma-Aldrich Corporation, a multinational biotechnology company, making them one of the major players in the PCR reagents market. In January 2017, Bio-Rad entered into an agreement to acquire RainDance Technologies to strengthen the digital PCR and liquid biopsy segments of the company.
Benefits:
The report provides complete details about the usage and adoption rate of PCR in various verticals and regions. This enables the key stakeholders to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward PCR adoption in the market. Moreover, the report provides details about the major challenges that are impacting the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business, increase their revenue, and analyze before investing or expanding the business in this market.
Key Stakeholders:
Title: Polymerase Chain Reaction (PCR) Market Trends 2017-2023
Desc: Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company will lead the Polymerase Chain Reaction (PCR) Market. Click to know more on Polymerase Chain Reaction (PCR) Market trends.
Keyword: Polymerase Chain Reaction, DNA, RNA, Polymerase Chain Reaction Market, Polymerase Chain Reaction Market Trends
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Next Generation Sequencing
3.3.2 In-situ Hybridization
3.3.3 Microarray
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Importance of Polymerase Chain Reaction
4.2.1 Medical Applications
4.2.2 Infectious Disease Diagnosis
4.2.3 Molecular Biology Research
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Polymerase Chain Reaction Technology Types
5.1.1 Real-Time PCR/qPCR
5.1.2 Nested PCR
5.1.3 Reverse Transcription PCR
5.1.4 Digital PCR
5.1.5 Assembly PCR
5.1.6 Multiplex PCR
5.1.7 Hot Start PCR
5.1.8 Others
5.2 Evolution
5.3 Polymerase Chain Reaction Advantages
5.4 Polymerase Chain Reaction Disadvantages
5.5 Market Dynamics
5.5.1 Drivers
5.5.1.1 Rising demand for PCR in genetic and molecular testing
5.5.1.2 Expiry of key PCR patents
5.5.1.3 Advent of digital PCR technology
5.5.2 Opportunities
5.5.2.1 Growth of personalized medicines
5.5.2.2 Growing applications in the fields of life sciences research and clinical diagnostics
5.5.3 Restraints
5.5.3.1 Lack of skilled labor
5.5.3.2 Competition from NGS and Microarray technology
5.5.3.3 Stringent government regulations
5.6 DRO – Impact Analysis
5.7 Key Stakeholders
6 PRODUCTS: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Instruments
6.2.1 Standard PCR
6.2.2 Quantitative PCR/Real Time PCR
6.2.3 Digital PCR
6.3 Reagents and Consumables
6.4 Software and Services
7 APPLICATION: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Clinical Diagnostics
7.3 Biomedical Research
7.4 Others
8 END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals and Laboratories
8.3 Pharmaceutical Companies
8.4 Academics
8.5 Others
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 Americas
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDOR PROFILES
11.1 Bio-Rad Laboratories
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Thermo Fisher Scientific Inc.
11.3.1 Overview
11.3.2 Geographic Presence
11.3.3 Business Focus
11.3.4 SWOT Analysis
11.3.5 Business Strategies
11.4 Abbott Laboratories
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Agilent Technologies Inc.
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 COMPANIES TO WATCH FOR
12.1 Becton Dickinson and Company
12.1.1 Overview
12.2 Merck KGaA
12.2.1 Overview
12.3 Danaher Corporation
12.3.1 Overview
12.4 Promega Corp.
12.4.1 Overview
12.5 QIAGEN N.V.
12.5.1 Overview
Annexure
Abbreviations
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Next Generation Sequencing
3.3.2 In-situ Hybridization
3.3.3 Microarray
4 MARKET OUTLOOK
4.1 Market Definition – Infoholic Research
4.2 Importance of Polymerase Chain Reaction
4.2.1 Medical Applications
4.2.2 Infectious Disease Diagnosis
4.2.3 Molecular Biology Research
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Polymerase Chain Reaction Technology Types
5.1.1 Real-Time PCR/qPCR
5.1.2 Nested PCR
5.1.3 Reverse Transcription PCR
5.1.4 Digital PCR
5.1.5 Assembly PCR
5.1.6 Multiplex PCR
5.1.7 Hot Start PCR
5.1.8 Others
5.2 Evolution
5.3 Polymerase Chain Reaction Advantages
5.4 Polymerase Chain Reaction Disadvantages
5.5 Market Dynamics
5.5.1 Drivers
5.5.1.1 Rising demand for PCR in genetic and molecular testing
5.5.1.2 Expiry of key PCR patents
5.5.1.3 Advent of digital PCR technology
5.5.2 Opportunities
5.5.2.1 Growth of personalized medicines
5.5.2.2 Growing applications in the fields of life sciences research and clinical diagnostics
5.5.3 Restraints
5.5.3.1 Lack of skilled labor
5.5.3.2 Competition from NGS and Microarray technology
5.5.3.3 Stringent government regulations
5.6 DRO – Impact Analysis
5.7 Key Stakeholders
6 PRODUCTS: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Instruments
6.2.1 Standard PCR
6.2.2 Quantitative PCR/Real Time PCR
6.2.3 Digital PCR
6.3 Reagents and Consumables
6.4 Software and Services
7 APPLICATION: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Clinical Diagnostics
7.3 Biomedical Research
7.4 Others
8 END-USERS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 Hospitals and Laboratories
8.3 Pharmaceutical Companies
8.4 Academics
8.5 Others
9 REGIONS: MARKET SIZE AND ANALYSIS
9.1 Overview
9.2 Americas
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World
10 COMPETITIVE LANDSCAPE
10.1 Overview
11 VENDOR PROFILES
11.1 Bio-Rad Laboratories
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Thermo Fisher Scientific Inc.
11.3.1 Overview
11.3.2 Geographic Presence
11.3.3 Business Focus
11.3.4 SWOT Analysis
11.3.5 Business Strategies
11.4 Abbott Laboratories
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Agilent Technologies Inc.
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 COMPANIES TO WATCH FOR
12.1 Becton Dickinson and Company
12.1.1 Overview
12.2 Merck KGaA
12.2.1 Overview
12.3 Danaher Corporation
12.3.1 Overview
12.4 Promega Corp.
12.4.1 Overview
12.5 QIAGEN N.V.
12.5.1 Overview
Annexure
Abbreviations
LIST OF TABLES
Table 1 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY PRODUCT TYPES, 2016–2023 ($MILLION)
Table 2 GLOBAL POLYMERASE CHAIN REACTION MARKET DEVICES REVENUE BY REGIONS, 2016–2023 ($MILLION)
Table 3 OTHER PROMINENT VENDORS
Table 4 BIO-RAD LABORATORIES: PRODUCT OFFERINGS
Table 5 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS
Table 6 F. HOFFMANN-LA ROCHE: PRODUCT OFFERINGS
Table 7 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS
Table 8 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
Table 9 THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS
Table 10 ABBOTT LABORATORIES: PRODUCT OFFERINGS
Table 11 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
Table 12 AGILENT TECHNOLOGIES INC.: PRODUCT OFFERINGS
Table 13 AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS
Table 14 BECTON DICKENSON AND COMPANY: RECENT DEVELOPMENTS
Table 15 MERCK KGAA: RECENT DEVELOPMENTS
Table 16 DANAHER CORPORATION: RECENT DEVELOPMENTS
Table 17 PROMEGA CORPORATION: RECENT DEVELOPMENTS
Table 18 QIAGEN N.V.: RECENT DEVELOPMENTS
Table 1 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY PRODUCT TYPES, 2016–2023 ($MILLION)
Table 2 GLOBAL POLYMERASE CHAIN REACTION MARKET DEVICES REVENUE BY REGIONS, 2016–2023 ($MILLION)
Table 3 OTHER PROMINENT VENDORS
Table 4 BIO-RAD LABORATORIES: PRODUCT OFFERINGS
Table 5 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS
Table 6 F. HOFFMANN-LA ROCHE: PRODUCT OFFERINGS
Table 7 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS
Table 8 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
Table 9 THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS
Table 10 ABBOTT LABORATORIES: PRODUCT OFFERINGS
Table 11 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
Table 12 AGILENT TECHNOLOGIES INC.: PRODUCT OFFERINGS
Table 13 AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS
Table 14 BECTON DICKENSON AND COMPANY: RECENT DEVELOPMENTS
Table 15 MERCK KGAA: RECENT DEVELOPMENTS
Table 16 DANAHER CORPORATION: RECENT DEVELOPMENTS
Table 17 PROMEGA CORPORATION: RECENT DEVELOPMENTS
Table 18 QIAGEN N.V.: RECENT DEVELOPMENTS
LIST OF CHARTS
Chart 1 PEST ANALYSIS OF GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 2 RESEARCH METHODOLOGY OF GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 3 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 4 POLYMERASE CHAIN REACTION STEPS
Chart 5 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY SEGMENTATION
Chart 6 PORTER 5 FORCES ON GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 7 DRO ANALYSIS – GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 8 DRO – IMPACT ANALYSIS OF GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 9 KEY STAKEHOLDERS
Chart 10 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY PRODUCT SEGMENTATION, 2016 (%)
Chart 11 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY PRODUCT SEGMENTATION, 2023 (%)
Chart 12 GLOBAL INSTRUMENTS MARKET REVENUE, 2016–2023 ($MILLION)
Chart 13 GLOBAL REAGENTS AND CONSUMABLES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 14 GLOBAL PCR SOFTWARE AND SERVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 15 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY APPLICATION SEGMENTATION, 2016 (%)
Chart 16 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY END-USER SEGMENTATION, 2016 (%)
Chart 17 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 18 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)
Chart 19 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 20 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN EUROPE, 2016–2023 ($MILLION)
Chart 21 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN ASIA PACIFIC, 2016–2023 ($MILLION)
Chart 22 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN REST OF THE WORLD, 2016–2023 ($MILLION)
Chart 23 BIO-RAD LABORATORIES: OVERVIEW SNAPSHOT
Chart 24 BIO-RAD LABORATORIES: BUSINESS UNITS
Chart 25 BIO-RAD LABORATORIES: GEOGRAPHICAL PRESENCE
Chart 26 BIO-RAD LABORATORIES: SWOT ANALYSIS
Chart 27 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT
Chart 28 F. HOFFMANN-LA ROCHE: BUSINESS UNITS
Chart 29 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE
Chart 30 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS
Chart 31 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT
Chart 32 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS REVENUE
Chart 33 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL PRESENCE
Chart 34 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
Chart 35 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
Chart 36 ABBOTT LABORATORIES: BUSINESS UNITS
Chart 37 ABBOTT LABORATORIES: GEOGRAPHICAL PRESENCE
Chart 38 ABBOTT LABORATORIES: SWOT ANALYSIS
Chart 39 AGILENT TECHNOLOGIES INC.: OVERVIEW SNAPSHOT
Chart 40 AGILENT TECHNOLOGIES INC.: BUSINESS UNITS
Chart 41 AGILENT TECHNOLOGIES INC.: GEOGRAPHICAL PRESENCE
Chart 42 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS
Chart 1 PEST ANALYSIS OF GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 2 RESEARCH METHODOLOGY OF GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 3 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 4 POLYMERASE CHAIN REACTION STEPS
Chart 5 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY SEGMENTATION
Chart 6 PORTER 5 FORCES ON GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 7 DRO ANALYSIS – GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 8 DRO – IMPACT ANALYSIS OF GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET
Chart 9 KEY STAKEHOLDERS
Chart 10 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY PRODUCT SEGMENTATION, 2016 (%)
Chart 11 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY PRODUCT SEGMENTATION, 2023 (%)
Chart 12 GLOBAL INSTRUMENTS MARKET REVENUE, 2016–2023 ($MILLION)
Chart 13 GLOBAL REAGENTS AND CONSUMABLES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 14 GLOBAL PCR SOFTWARE AND SERVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 15 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY APPLICATION SEGMENTATION, 2016 (%)
Chart 16 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY END-USER SEGMENTATION, 2016 (%)
Chart 17 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 18 GLOBAL POLYMERASE CHAIN REACTION DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)
Chart 19 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 20 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN EUROPE, 2016–2023 ($MILLION)
Chart 21 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN ASIA PACIFIC, 2016–2023 ($MILLION)
Chart 22 POLYMERASE CHAIN REACTION DEVICES MARKET REVENUE IN REST OF THE WORLD, 2016–2023 ($MILLION)
Chart 23 BIO-RAD LABORATORIES: OVERVIEW SNAPSHOT
Chart 24 BIO-RAD LABORATORIES: BUSINESS UNITS
Chart 25 BIO-RAD LABORATORIES: GEOGRAPHICAL PRESENCE
Chart 26 BIO-RAD LABORATORIES: SWOT ANALYSIS
Chart 27 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT
Chart 28 F. HOFFMANN-LA ROCHE: BUSINESS UNITS
Chart 29 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE
Chart 30 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS
Chart 31 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT
Chart 32 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS REVENUE
Chart 33 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL PRESENCE
Chart 34 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
Chart 35 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
Chart 36 ABBOTT LABORATORIES: BUSINESS UNITS
Chart 37 ABBOTT LABORATORIES: GEOGRAPHICAL PRESENCE
Chart 38 ABBOTT LABORATORIES: SWOT ANALYSIS
Chart 39 AGILENT TECHNOLOGIES INC.: OVERVIEW SNAPSHOT
Chart 40 AGILENT TECHNOLOGIES INC.: BUSINESS UNITS
Chart 41 AGILENT TECHNOLOGIES INC.: GEOGRAPHICAL PRESENCE
Chart 42 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS
